Effects of Pretreatment with Fluvastatin on Serum Interleukin-8 and Areas of Myocardial Infarction in Reperfusion Injury Rabbits after Myocardial Infarction

GUO Lei,WU Yanqing,CAO Yuan,ZOU Bin,CHENG Xiaoshu
DOI: https://doi.org/10.3969/j.issn.1001-1439.2006.04.008
2006-01-01
Journal of Clinical Cardiology
Abstract:Objective:To investigate the effects of the pretreatment with fluvastatin on serum interleukin-8 and areas of myocardial infarction (MI) in reperfusion injury rabbits after MI.Method:Twenty-four male New Zealand white rabbits were randomly divided into three groups: sham group(n=8), control group(n=8) and fluvastatin group(n=8). Both of the former 2 groups were fed daily with ordinary food while the animals of fluvastatin group pretreated with fluvastatin 10 mg·kg -1·d -1. Models of ischemia/reperfusion were established in both control and fluvastatin groups by a sixty-minute coronary occlusion followed by a three-hour reperfusion. Blood samples were extracted from the right atrium of the animals, and the sera were collected with hypothermia high speed centrifugation for the measurement of IL-8 and creatine kinase-MB (CK-MB). MI size was determined by triphenyltetrazolium chloride staining, and the cardiac muscle in MI was frozed for detecting myeloperoxidase (MPO).Result:In control and fluvastatin groups, the levels of serum IL-8 , MPO, and CK-MB were all elevated significantly compaired with those in sham group,especially those in control group, P0.05. further more, MI sizes of animals in Fluvastatin were markedly smaller than those in control group ([26.90±1.81]% vs [31.22±2.33]%, P0.05).Conclusion:Fluvastatin could improve myocardial ischemia/reperfusion injury by inhibiting the product of IL-8 and reducing inflammatory cell infiltration.
What problem does this paper attempt to address?